[ET Net News Agency, 23 October 2025] REMEGEN (09995) fell 10.1% to HK$82.7.
It hits an intra-day low of HK$82.2, hitting an 1-month low, and an intra-day high of
HK$91.2. The total shares traded was 5.43 million, with a value of HK$466.81m. The active
buy/sell ratio is 39:61, with net selling turnover of HK$96.6m. UBS accounts for greatest
net responsive buying turnover of HK$11.41m, with volume weighted average price of
HK$85.34. CHINA INNOVATION MARKET SER accounts for greatest net responsive selling
turnover of HK$7.8m, with volume weighted average price of HK$86.042. The stock has fallen
a combined 14.2% over the past 2 consecutive trading days.

Basic Information
=================

-----------------------------------
Nominal 82.700 % Chg -10.06%
High 91.200 Low 82.200
Shares Tr 5.43m Turnover 466.81m
10-D SMA 91.725 %H.V 86.204
20-D SMA 102.788 VWAP 86.009
50-D SMA 97.655 RSI14 36.077
-----------------------------------
Status: Hitting an 1-month low, active buy/sell ratio is 39:61, with net selling turnover
of HK$96.6m, falling a combined 14.2% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
REMEGEN (09995) 82.70 -10.06
SINO BIOPHARM (01177) 6.92 -3.89
3SBIO (01530) 26.28 -4.64
EVEREST MED (01952) 48.28 -3.29
WUXI XDC (02268) 64.65 -4.72
ASCENTAGE-B (06855) 64.65 -4.36
SKB BIO-B (06990) 425.60 -6.13
DUALITYBIO-B (09606) 305.00 -3.05
ZAI LAB (09688) 21.80 -4.55
AKESO (09926) 112.70 -3.26
---------------------------------------------
(ed)